1218.43.97002 Boehringer Ingelheim Investigational Site

Kfar Saba

0 studies enrolling now · 1 studies all time

What they study most

Diabetes Mellitus, Type 2

Studies at this site

• Safety and Efficacy in Type 2 Diabetic Patients With Severe Chronic Renal Impairment, 5 mg BI 1356 (Linagliptin) vs. Placebo, Insulin Background Inclusive — Completed